Source: CNS Spectrums: International Journal of Neuropsychiatric Medicine. Unidade: FM
Subjects: ESQUIZOFRENIA (TERAPIA), ESCALAS DE GRADUAÇÃO PSIQUIÁTRICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Irismar Reis de et al. Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: An Open-Label, Randomized, Study Versus Haloperidol. CNS Spectrums: International Journal of Neuropsychiatric Medicine, v. 14, n. 2, p. 93-102, 2009Tradução . . Disponível em: https://doi.org/10.1017/s1092852900000249. Acesso em: 01 out. 2024.APA
Oliveira, I. R. de, Elkis, H., Gattaz, W. F., Chaves, A. C., Sena, E. P. de, Souza, F. G. de M. e, et al. (2009). Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: An Open-Label, Randomized, Study Versus Haloperidol. CNS Spectrums: International Journal of Neuropsychiatric Medicine, 14( 2), 93-102. doi:10.1017/s1092852900000249NLM
Oliveira IR de, Elkis H, Gattaz WF, Chaves AC, Sena EP de, Souza FG de M e, Campos JA, Bueno JR, Silva JAC e, Louzã MR, Abreu PB de. Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: An Open-Label, Randomized, Study Versus Haloperidol [Internet]. CNS Spectrums: International Journal of Neuropsychiatric Medicine. 2009 ; 14( 2): 93-102.[citado 2024 out. 01 ] Available from: https://doi.org/10.1017/s1092852900000249Vancouver
Oliveira IR de, Elkis H, Gattaz WF, Chaves AC, Sena EP de, Souza FG de M e, Campos JA, Bueno JR, Silva JAC e, Louzã MR, Abreu PB de. Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: An Open-Label, Randomized, Study Versus Haloperidol [Internet]. CNS Spectrums: International Journal of Neuropsychiatric Medicine. 2009 ; 14( 2): 93-102.[citado 2024 out. 01 ] Available from: https://doi.org/10.1017/s1092852900000249
